Patient materials
Access materials to support your haemophilia patients.

Pfizer and Haemophilia

Contact Pfizer
Speak to a member of the Pfizer Haemophilia team by using the form below.

BeneFIX®
Click here to visit the BeneFIX homepage

ReFacto AF®
Click here to visit the ReFacto homepage

What is haemophilia?
Haemophilia is a lifelong condition requiring constant and careful management. The most common forms of haemophillia are caused by deficiency in a particular coagulation factor – factor VIII (FVIII) in haemophilia A and factor IX (FIX) in haemophilia B.
Haemophilia is quite rare; about 1 in 10,000 people are born with it1.
Treatment of haemophilia
A primary aim of care in haemophilia is to prevent and treat bleeding with the deficient clotting factor2:
- On-demand: Treatment given at the time of clinically evident bleeding
- Prophylaxis: Treatment given in order to prevent anticipated bleeding
References: 1. World Federation of Hemophilia. What is Hemophilia? Available at: http://www1.wfh.org/publications/files/pdf-1324.pdf (accessed April 2019). 2.World Federation of Hemophilia. Guidelines for the Management of Hemophilia–2nd Edition. Available at: http://www1.wfh.org/publications/files/pdf-1472.pdf (accessed April 2019).
PP-BEN-GBR-0264, April 2019
Click here for BeneFIX® prescribing information. |